Evaluation of non-vendor magnetic resonance imaging sequences for use in bladder cancer magnetic resonance image guided radiotherapy.
Phys Imaging Radiat Oncol
; 27: 100481, 2023 Jul.
Article
em En
| MEDLINE
| ID: mdl-37655122
ABSTRACT
Hybrid systems that combine Magnetic Resonance Imaging (MRI) and linear accelerators are available clinically to guide and adapt radiotherapy. Vendor-approved MRI sequences are provided, however alternative sequences may offer advantages. The aim of this study was to develop a systematic approach for non-vendor sequence evaluation, to determine safety, accuracy and overall clinical application of two potential sequences for bladder cancer MRI guided radiotherapy. Non-vendor sequences underwent and passed clinical image qualitative review, phantom quality assurance, and radiotherapy planning assessments. Volunteer workflow tests showed the potential for one sequence to reduce workflow time by 27% compared to the standard vendor sequence.
Texto completo:
1
Bases de dados:
MEDLINE
Tipo de estudo:
Qualitative_research
Idioma:
En
Revista:
Phys Imaging Radiat Oncol
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Reino Unido